News tagged with tb
Scientists take step toward simple and portable tuberculosis tests for developing world
Oct 08, 2009 |
5 / 5 (1) |
0
Two billion people worldwide carry the pathogen that causes tuberculosis (TB), and most of them do not even know they are infected. This is because some 90 percent of people with TB have "latent" infections. They have no ...
New test quickly ID's active TB in smear-negative patients
Sep 23, 2009 |
not rated yet |
0
Active tuberculosis can be rapidly identified in patients with negative sputum tests by a new method, according to European researchers. Active tuberculosis (TB) is the seventh-leading cause of death worldwide, and while ...
Researchers discover new antituberculosis compounds
Sep 16, 2009 |
4.9 / 5 (7) |
0
Attempts to eradicate tuberculosis (TB) are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells. Now, a team of scientists led by researchers from Weill ...
Inhibitors of Important Tuberculosis Survival Mechanism Identified
Sep 16, 2009 |
not rated yet |
0
(PhysOrg.com) -- Attempts to eradicate tuberculosis (TB) are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells. Now, a team of scientists ...
Analysis of TB treatment studies identifies gaps in guidelines
Sep 15, 2009 |
not rated yet |
0
International guidelines for treating tuberculosis are due for specific improvements, according to two research papers published this week in the open access journal PLoS Medicine.
New drug-resistant TB strains could become widespread, says new study
Aug 10, 2009 |
1 / 5 (1) |
0
The emergence of new forms of tuberculosis could swell the proportion of drug-resistant cases globally, a new study has found. The finding raises concern that although TB incidence is falling in many regions, the emergence ...
Misuse of common antibiotic is creating resistant TB
Aug 10, 2009 |
not rated yet |
0
Use of a common antibiotic may be undercutting its utility as a first-line defense against drug-resistant tuberculosis (TB). Fluoroquinolones are the most commonly prescribed class of antibiotics in the U.S. and are used ...
Animal TB 'tracker' to speed drug and vaccine studies
Jul 22, 2009 |
not rated yet |
0
Johns Hopkins researchers have developed a novel way to monitor in real time the behavior of the TB bacterium in mouse lungs noninvasively pinpointing the exact location of Mycobacterium tuberculosis. The ...
WHO paper: TB vaccine could kill babies with HIV
Medicine & Health / HIV & AIDS
Jul 01, 2009 |
5 / 5 (1) |
0
(AP) -- The World Health Organization says a study has shown that babies with HIV could die if given a standard tuberculosis vaccine.
Risk of tuberculosis from arthritis medication examined
Jun 30, 2009 |
1.5 / 5 (2) |
0
Treatment with anti-tumor necrosis factor (TNF) agents is recognized as a risk factor for tuberculosis (TB) in patients with immune-mediated inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, Crohn's ...
Measurements fail to identify TB patients who could benefit from shorter treatment course
Jun 30, 2009 |
not rated yet |
0
Tuberculosis (TB) is a difficult infection to treat and requires six months of multiple antibiotics to cure it. To combat the TB pandemic, a shorter and simpler drug treatment would be a huge advance since most TB occurs ...
Scientists solve mystery about why HIV patients are more susceptible to TB infection
Medicine & Health / HIV & AIDS
Jun 30, 2009 |
not rated yet |
0
A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection. In their report, appearing in the July 2009 p ...
TB vaccine gets its groove back
May 19, 2009 |
4 / 5 (4) |
2
A team of Vanderbilt University Medical Center investigators has cracked one of clinical medicine's enduring mysteries - what happened to the tuberculosis vaccine. The once-effective vaccine no longer prevents the bacterial ...
TB vaccine enters new clinical trials
Medicine & Health / Medications
Apr 23, 2009 |
1 / 5 (1) |
0
(PhysOrg.com) -- The world’s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate vaccine ...
Tijuana injection drug users on collision course for HIV and TB
Apr 15, 2009 |
1 / 5 (1) |
0
A study by researchers from the University of California, San Diego School of Medicine, in collaboration with Mexican researchers and health officials, shows that as many as 67 percent of injection drug users in Tijuana test ...
